AI helps surgeons spot skin cancer cells during surgery

NCT ID NCT06600165

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether artificial intelligence (AI) can help surgeons analyze microscope images of skin cancer tissue during surgery. The goal is to give surgeons real-time feedback so they can remove all cancer cells in one go. The trial will enroll 1,000 people with basal cell carcinoma, a common skin cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a tool that helps surgeons remove skin cancer more completely in a single surgery, reducing the need for repeat procedures.

What could go wrong

This is an early-stage study focused on developing and testing the AI tool, not yet proving it improves patient outcomes. The technology may not work as well in real-world settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

basal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinic and Policlinic of Dermatology and Allergy, LMU Munich

    RECRUITING

    Munich, Bavaria, 80337, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••